Pericarditis Treatment in India & UAE

Pericarditis treatment in India from $1,200. Acute, recurrent and constrictive pericarditis management at Apollo, Medanta, Fortis. Expert cardiologists and cardiac surgeons. Book now.

Estimated cost: $1,200 – $5,000 · Average stay: 3–7 days

Pericarditis — inflammation of the pericardium, the two-layered fibrous sac surrounding the heart — is the most common disease of the pericardium and an important cause of chest pain in young and middle-aged adults. Acute pericarditis presents with sharp, pleuritic chest pain (worse lying flat, better leaning forward), pericardial friction rub (a characteristic scratchy sound heard on auscultation), ECG changes (widespread ST elevation with PR depression in the early phase), and elevated inflammatory markers (CRP, ESR, white cell count). Most cases are idiopathic (presumed viral) and respond well to anti-inflammatory therapy, resolving completely within 4–6 weeks.

The major clinical concerns in pericarditis are: pericardial effusion (fluid accumulation between the pericardial layers); cardiac tamponade (when effusion is large and under pressure, compressing the heart and preventing filling — a life-threatening emergency requiring urgent pericardiocentesis — needle drainage); recurrent pericarditis (occurring in 15–30% of patients after a first episode, particularly when not treated adequately with anti-inflammatory therapy); and constrictive pericarditis (the late complication of pericarditis where the pericardium scars, thickens, and calcifies, restricting cardiac filling — requiring surgical pericardiectomy for definitive treatment).

India's cardiologists at Apollo Hospitals, Medanta – The Medicity, Max Hospital, Fortis, and the country's cardiac surgery programs are experienced in the full spectrum of pericardial disease — from outpatient management of acute pericarditis through to the technically demanding pericardiectomy for constrictive pericarditis. Pericarditis is common in India due to the high burden of tuberculosis (the most common cause of chronic and constrictive pericarditis in India) and viral illness.

Types of Pericarditis and Their Causes

Acute Pericarditis: The most common form — typically presenting in young adults with acute sharp chest pain. In high-income countries, 80–90% of cases are idiopathic (viral origin, without proven viral cause). In lower-income countries — and in India particularly — tuberculosis is the most important identifiable cause. Other causes include: autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, scleroderma); bacterial infection; malignancy (direct invasion or pericardial metastases); uraemia from kidney failure; post-cardiac injury syndrome (post-MI, post-cardiac surgery, or post-ablation pericarditis — Dressler's syndrome); and radiation pericarditis.

Pericardial Effusion: Fluid accumulation between the pericardial layers — can be small (incidental), moderate, or large. The rate of accumulation determines clinical impact: slowly accumulating effusions can be very large (2+ liters) without symptoms because the pericardium gradually stretches; rapidly accumulating effusions of even 150–200 mL can cause tamponade.

Cardiac Tamponade: Emergency — rapid fluid accumulation compresses the right (then left) ventricle, preventing cardiac filling and output. Beck's triad: hypotension, elevated JVP, muffled heart sounds. Pulsus paradoxus (BP falls more than 10 mmHg with inspiration). Requires immediate pericardiocentesis.

Recurrent Pericarditis: Most common complication — occurs in 15–30% after first episode. Treated with colchicine added to NSAIDs. Refractory recurrent pericarditis (multiple recurrences despite colchicine) is now treated with IL-1 antagonists (anakinra, rilonacept — FDA-approved).

Constrictive Pericarditis: The scarred, thickened, calcified pericardium (pericardial thickness above 3–4 mm on CT — normal is 1–2 mm) restricts cardiac filling, causing right heart failure, ascites, peripheral oedema, and hepatic congestion — mimicking liver cirrhosis. The cause is most commonly tuberculosis in India; radiation therapy and viral pericarditis in Western countries. Diagnosed by echocardiography (septal bounce, respiratory variation in filling velocities), cardiac MRI, and CT (pericardial thickness and calcification). Treated definitively by surgical pericardiectomy.

Who Needs Pericardiectomy for Constrictive Pericarditis?

Pericardiectomy is indicated for constrictive pericarditis causing: significant right heart failure symptoms (ascites, oedema, hepatic congestion); haemodynamic compromise confirmed by equalization of diastolic filling pressures on cardiac catheterization; and when the constriction has not resolved with anti-inflammatory therapy (transient constriction after acute pericarditis resolves in 30–50% of cases with NSAIDs and colchicine within 3 months, particularly in young patients).

Patients with effusive-constrictive pericarditis (where pericardial effusion and constriction coexist) may require both pericardiocentesis and eventual pericardiectomy. Patients with radiation-induced constrictive pericarditis should be assessed for concurrent myocardial and coronary disease (radiation also damages these structures) before surgery.

Medical management (diuretics) provides temporary palliation of constrictive pericarditis symptoms but does not reverse the underlying mechanical restriction. Pericardiectomy — when complete (radical resection including right ventricular surface) — provides definitive relief in 70–85% of patients.

Pericarditis Treatment Approaches

Acute Idiopathic/Viral Pericarditis: Anti-inflammatory therapy — aspirin (750–1,000 mg three times daily for 1–2 weeks, then tapering) or ibuprofen (600 mg three times daily) combined with colchicine 0.5 mg twice daily for 3 months. Colchicine halves the recurrence rate and is now standard of care. Rest during the acute phase; restriction from intense exercise until CRP normalizes.

Tuberculous Pericarditis: Anti-tuberculous therapy (RHEZ regimen — rifampicin, isoniazid, ethambutol, pyrazinamide — for 2 months, then RH for 4 months) combined with corticosteroids (prednisolone 1 mg/kg/day tapering over 6–8 weeks) — corticosteroids reduce the risk of progression to constriction.

Pericardial Effusion with Tamponade: Emergency pericardiocentesis — ultrasound-guided needle drainage via the subxiphoid approach, with real-time echocardiographic visualization. A pigtail catheter is left in the pericardial space for continuous drainage. Fluid is sent for cytology, culture (bacterial, TB), and biochemical analysis (to characterize the effusion).

Recurrent Pericarditis: Colchicine 0.5 mg twice daily for 6 months. Refractory recurrences: low-dose oral corticosteroids (prednisolone 0.25–0.5 mg/kg/day, slow taper over months); IL-1 antagonists (anakinra 100 mg subcutaneously daily, or rilonacept 320 mg loading then 160 mg weekly).

Constrictive Pericarditis (surgical): Pericardiectomy — surgical removal of the entire thickened pericardium from the surface of both ventricles. Performed through a median sternotomy, with or without cardiopulmonary bypass. The epicardium (the outer surface of the heart muscle) is carefully freed from the adherent, calcified pericardium. A technically demanding procedure — the scar tissue can be intimately adherent to coronary arteries and the right ventricular wall.

Procedure Steps

1. Diagnosis: ECG (ST elevation, PR depression in acute pericarditis); echocardiography (effusion, chamber compression, septal bounce for constriction); chest X-ray; CBC, CRP, ESR, cardiac troponin (elevated in myopericarditis); ANA, anti-dsDNA (for autoimmune); tuberculin test and IGRA (TB pericarditis).
2. Acute pericarditis treatment: aspirin or ibuprofen + colchicine 0.5 mg BD × 3 months; exercise restriction; NSAIDs with meals (gastroprotection with PPI).
3. Monitoring: CRP at 1 week, 3 weeks, and 3 months to guide treatment duration; return to exercise only after CRP normalization.
4. Pericardial effusion assessment: echo-guided; large or symptomatic effusions — pericardiocentesis; fluid analysis for TB, malignancy, bacteria.
5. TB pericarditis: anti-TB therapy × 6 months + prednisolone taper × 8 weeks; serial echo for early constriction detection.
6. Constrictive pericarditis: cardiac catheterization to confirm haemodynamic constriction (equalization of diastolic filling pressures); cardiac CT for pericardial thickness and calcification; surgical referral.
7. Pericardiectomy: median sternotomy; radical excision of thickened/calcified pericardium from all ventricular surfaces; RV decompression; bypass machine on standby for RV injury.
8. Post-pericardiectomy: ICU 2–3 days; persistent right heart failure (may take weeks to months to resolve as the ventricles gradually ‘remember’ how to fill); diuretics titrated carefully.

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $15,000 – $50,000 — Baseline

United Kingdom — $8,000 – $25,000 — ~48% savings vs. USA

India — $1,200 – $8,000 (medical or surgical) — Up to 85% savings vs. USA

UAE — $3,000 – $15,000 — ~65% savings vs. USA

Acute pericarditis medical management packages in India are very affordable — outpatient or short hospitalization for investigation and anti-inflammatory therapy initiation. Pericardiectomy for constrictive pericarditis costs $5,000–$8,000 in India all-inclusive. Pericardiocentesis with pigtail catheter drainage and hospital stay is $1,200–$2,500.

Recovery & Follow-up

Acute pericarditis: most patients recover fully within 4–6 weeks with appropriate anti-inflammatory therapy. Colchicine reduces recurrence risk. Exercise restriction is maintained until CRP normalizes — typically 2–6 weeks. Recurrence occurs in 15–30% without colchicine; under 15% with 3 months of colchicine.

Pericardiectomy recovery: ICU 2–3 days; total hospital stay 10–14 days. Post-operative right heart failure — from the sudden unloading of the chronically restricted ventricle — requires careful diuretic management and may persist for weeks to months while the RV "relearns" normal filling. Full symptomatic benefit is evident at 3–6 months in most patients. Functional class (NYHA) improves by one to two categories in most patients after complete pericardiectomy.

Recovery Tips

• Take colchicine for the full 3 months prescribed — this is the single most important measure to prevent recurrence.
• Do not return to competitive sports or strenuous exercise until CRP is confirmed normal by blood test.
• Monitor for worsening breathlessness, leg swelling, or fever — these may indicate recurrence or complications.
• For TB pericarditis: complete the full 6-month anti-TB regimen without interruption — resistance develops with partial treatment.
• Post-pericardiectomy: continue diuretics as directed — the resolution of right heart failure after surgery takes weeks to months.

Risks & Complications

Acute pericarditis medical management is very safe. NSAIDs carry GI side effects (mitigated with PPI); colchicine rarely causes diarrhoea (dose-reducible). Pericardiectomy carries a mortality of 5–10% for severely ill patients with severe long-standing constriction; 2–5% for less advanced disease. Specific risks: RV injury during pericardial stripping (rare but catastrophic); prolonged post-operative right heart failure; incomplete resection leaving residual constriction (10–15%); and phrenic nerve injury causing diaphragmatic palsy (rare).

Why GAF Healthcare

Gaf Healthcare coordinates pericarditis diagnosis and management — from acute idiopathic cases through to TB pericarditis management and surgical pericardiectomy — at India's leading cardiac centers. Our cardiac coordinators work with both cardiologists (for medical pericarditis) and cardiac surgeons (for pericardiectomy) depending on disease stage and clinical requirements.

Frequently Asked Questions

How long does pericarditis last?

Most cases of acute idiopathic/viral pericarditis resolve within 4–6 weeks with aspirin/ibuprofen and colchicine. Recurrent episodes occur in 15–30% of patients without adequate colchicine therapy. Constrictive pericarditis (a chronic complication) requires surgical pericardiectomy for definitive treatment.

What is the best treatment for recurrent pericarditis?

Colchicine 0.5 mg twice daily for 6 months is the most effective prevention of recurrence, reducing risk by approximately 50%. For refractory recurrences despite colchicine, IL-1 antagonists (anakinra or rilonacept) are now FDA-approved and highly effective (85–90% recurrence reduction in clinical trials).

What is constrictive pericarditis?

Constrictive pericarditis occurs when the pericardium scars and thickens (typically from tuberculosis, viral pericarditis, or radiation) and encases the heart, preventing normal cardiac filling. It causes right heart failure — ascites, leg swelling, and liver congestion. Surgical pericardiectomy (removal of the thickened pericardium) is the definitive treatment.